News

A new form of CRISPR technology that takes advantage of a compact RNA-editing protein could lead to improved diagnostic tests for COVID-19.

A computational tool allows researchers to predict locations on the surfaces of human and COVID-19 viral proteins that bind with each other. This knowledge will help to develop drugs that block binding sites on SARS-CoV-2.

Researchers have developed a device that detects viruses like COVID-19 in the body as fast as and more accurately than current, commonly used rapid detection tests.

Northwestern University scientists have developed a novel in vitro method for using DNA to record and store information. The work has implications for the current data storage crisis and other scientific fields, such as neuroscience research.

A research team has uncovered a new mechanism to explain how obesity jeopardizes the functions of skeletal muscle and provides a potential treatment against the disease.

An international research team have discovered a specific type of gut bacteria in bees that can improve memory.

New highly sensitive quantum sensors for the brain may in the future be able to identify brain diseases such as dementia, ALS and Parkinson's, by spotting a slowing in the speed at which signals travel across the brain.

In the primary visual cortex (V1), high-contrast visual stimuli elicit strong responses and vice versa. Researchers found that in rats, the number of V1 neurons preferentially responding to low-contrast stimuli increases after repeated experiences.

A $4.1 million grant has been approved to enable researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.

It is now widely known that COVID-19 is associated with the transient or long-term loss of olfaction (the sense of smell) but the mechanisms remain obscure. Scientists report that SARS-CoV-2 does not appear to infect the sensory neurons of the olfactory epithelium in COVID-19 patients.